Advancing corticosteroids and hormonal therapies for supply and scale

Episode 201

0:00-27:03

Today we’re diving into the world of corticosteroids and hormonal therapies — essential APIs that treat everything from asthma and autoimmune diseases to diabetes and endocrine disorders. These molecules may be decades old, but their manufacturing remains highly complex and critical to patients worldwide. Our guest is Olivier Roux, a Senior Director at Curia. He shares how Curia partners with both startups and big pharma to simplify steroid API challenges, solve supply issues, and prepare for next-generation innovations. If you want to understand what it really takes to bring these life-changing therapies to patients, stay tuned — this conversation is packed with insights you won’t want to miss. 01:39 Meet Olivier Roux 02:20 What corticosteroids and hormonal therapies are 04:40 Evolution of steroidal hormonal therapies 05:50 Common uses of corticosteroids today 07:40 Key drivers of market growth 10:06 Curia’s agile outsourcing solutions for steroids 16:05 Importance of particle size control for steroids 17:18 Aseptic processing and high potency handling This episode was produced with the support of Curia. Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletter To dive deeper into the topic: Eight rare autoimmune diseases biotechs are fighting to treat A clearer path to relief: sinusitis treatments on the way Asthma study suggests lung scarring may be reversible

Publisher

Beyond Biotech - the podcast from Labiotech

Published

June 12, 2026

Duration

27 min

Format

Podcast

Category

Issues · Tech News

Source

RSS feed

Host

Labiotech

BB

Beyond Biotech - the podcast from Labiotech

@beyondbiotechthepodcastfroml

#advancingcorticosteroids #hormonaltherapies #supply

The Nile